Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-07
2006-02-07
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S201000
Reexamination Certificate
active
06995176
ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
REFERENCES:
patent: 5567711 (1996-10-01), Sheppard et al.
patent: 6727246 (2004-04-01), Bernotas et al.
patent: 2005/0020575 (2005-01-01), Cole et al.
patent: WO97 49382 (1997-12-01), None
patent: WO97 49698 (1997-12-01), None
patent: WO97 49699 (1997-12-01), None
patent: WO03 013510A (2003-02-01), None
Allen et al. “Preparation of 4-heterocyclyl-1- . . . ”CA 128:102084 (1998).
Bernotas Ronald Charles
Lenicek Steven Edward
Chang Celia
Lences Barbara L.
Wyeth
LandOfFree
1-heterocyclylalkyl-3-sulfonyl-indole or -indazole... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707607